Reported about 23 hours ago
Bionexus Gene Lab (BGLC) has established a strategic partnership with ML Tech to enhance its Ethereum-based growth strategies. This collaboration will see BGLC utilize ML Tech's sophisticated digital asset trading infrastructure to expand its Ethereum portfolio, benefiting from tailored investment solutions that aim to maximize returns while ensuring robust risk management.
Source: YAHOO